Sonalis Consumer Products Limited

Consumer Defensive — Packaged Foods · BSE

₹34.98−₹0.01 (−0.03%)

DalalBaazaar Score

66 / 100

🟢 Good

Verdict

REASONABLE

Risk

Very High

Driven by high debt relative to equity, negative free cash flow, micro-cap size, which brings thin liquidity.

In simple words: Strong business and financial position, with modest growth. Debt is the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 6:07 pm

Mixed / neutral. No major red flags jump out, but nothing here screams "obviously cheap" either. This is a name that needs a peer comparison and a view on near-term earnings triggers before sizing a position.

Understanding the Business

Company site ↗

The 60-second version of Sonalis Consumer Products Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Sonalis Consumer Products Limited manufactures and sells nutritious bars and snacks in India. The company provides a portfolio of products comprising granola bars, healthy laddus, puffs, cheeselings, chakli, diet bhel, and sev, as well as grains.

IndustryPackaged Foods

SectorConsumer Defensive

Annual revenue₹150 Cr

How does it make money?

Turns over ₹150 Cr a year. Of every ₹100 of sales, about ₹6 reaches shareholders as profit, with ₹7 left at the operating level before interest, tax and depreciation.

EBITDA margin7.4%

Net margin5.8%

Who are its competitors?

The closest listed comparisons in its industry are NESTLE INDIA LIMITED, BRITANNIA INDUSTRIES LTD, TATA CONSUMER PRODUCT LTD, DABUR INDIA LTD. These are the companies its valuation and returns are measured against elsewhere in this report.

NESTLE INDIA LIMITEDP/E 59.8x · ROE 79.9%

BRITANNIA INDUSTRIES LTDP/E 44.1x · ROE 51.0%

TATA CONSUMER PRODUCT LTDP/E 59.3x · ROE 7.5%

DABUR INDIA LTDP/E 34.7x · ROE 17.2%

What is its competitive advantage?Some evidence

ROCE of 30.5% is above what capital typically costs, which suggests some pricing power, though not yet the sustained, wide gap that marks a durable advantage.

ROCE30.5%

ROE42.1%

Peer median ROE51.0%

What has been driving growth?

Profit has moved mainly because margins changed, not because the business sold much more. Over 3 years revenue moved +2195% while net margin moved +12492% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+2195%

Margin effect+12492%

DalalBaazaar Score

66/ 100

Good

Weighted across six categories. Every point is explained below.

• Beta of 1.11 — moves roughly with the market
✗ Micro Cap: thinner liquidity and sharper drawdowns are normal
✗ High leverage magnifies any downturn in earnings
✗ Profits have swung sharply from year to year — earnings are hard to forecast
✗ Negative free cash flow means dependence on external funding

Quality vs. Valuation

Company Quality

66/ 100

Good

How good the business is, ignoring the share price entirely.

Valuation

88/ 100

Cheap

What you are being asked to pay, ignoring how good the business is.

A good business currently available at an undemanding price — the combination this framework is built to look for.

Historical Valuation

Current P/E

1.9x

3Y Median

2618.1x

40 monthly readings · mean 3230.4x · range 2.6x–9026.0x

Sector Median

51.7x

median of 4 sector peers

🟢Current valuation is approximately 100% below its 3y median of 2618.1x. Cheaper than its own history, which is worth a reason too: the market may be pricing in something the backward-looking numbers do not show.

🟢Against its sector it trades 96% below the peer median of 51.7x.

vs. its own history

Cheap

2618.1x median over 40 months · -100%

vs. sector peers

Cheap

51.7x median of 4 peers · -96%

vs. generic bands

Cheap

Below 15x

P/E (Trailing)

1.9x

P/B

0.51x

EV/EBITDA

1.7x

PEG

0.00

Dividend Yield

None

What's Good / What's Bad

🟢 What's Going Well6

Margins are improving
EBITDA margin is up from 2.2% to 7.4% over 3 years.
Return on equity is rising
ROE has improved from 0.1% to 26.4%.
Return on capital is rising
ROCE has improved from 0.7% to 30.5%.
High return on capital employed
ROCE of 30.5% is the mark of a business that converts capital into profit efficiently.
Valuation below its historical average
At 1.9x the stock trades 100% below its own median of 2618.1x.
Consistently profitable
Profitable in every one of the last 4 reported years.

🔴 What Needs Attention2

Free cash flow is negative
The business is not currently covering its capital spending from operations.
Receivables growing faster than sales
Receivables are up 3529% against revenue growth of 2195% — customers are taking longer to pay.

Red Flags

5 items require attention · 4 high · 1 watch

🔴High leverageFinancial
Debt/Equity of 8.42x — earnings must service borrowings before shareholders see anything.
🔴Free cash flow negative for 4 yearsFinancial
The business has not covered its capital spending from operations for several years running, which has to be funded externally.
🔴Profit up while operating cash flow fallsFinancial
Reported profit rose but cash generated by operations declined — worth checking whether earnings are being supported by non-cash items or working capital.
🔴Receivables growing faster than salesFinancial
Receivables up 3529% against revenue up 2195% — sales are being booked faster than they are collected.
🟡Shareholders have been dilutedOwnership
Shares outstanding are up 133% over 3 years — each existing share owns a smaller slice of the company.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Capital compounds at a high rate
ROCE of 30.5% means each rupee reinvested earns well above what capital costs. If the company can keep deploying at this rate, growth creates value rather than just consuming cash.
Margin expansion has further to run
EBITDA margin has risen from 2.2% to 7.4%. If that holds, profit compounds faster than sales and today's multiple looks cheaper in hindsight than it does now.
Priced below its own history
The stock trades 100% below its own median multiple. If the business performs as it has and simply re-rates back to normal, that gap is return on its own.
Cheaper than its peers
It trades 96% below the sector median. Either the market sees a problem the numbers do not show, or the discount closes.
Earnings have proved durable
Profitable in every one of the last 4 reported years. Consistency lowers the risk that any single bad year is structural rather than cyclical.

🔴 Bear CaseWhat could go wrong?

Leverage amplifies any setback
Debt/Equity of 8.42x. Interest is payable whether or not the business has a good year.
Sales are being booked faster than collected
Receivables are up 3529% against revenue up 2195%. If customers keep taking longer to pay, reported profit will not turn into cash — and write-offs follow if some never do.
Earnings are hard to forecast
Profit has swung sharply from year to year, so any single year — good or bad — is a weak guide to the next. Cyclical earnings deserve lower multiples for that reason.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.
Several serious flags at once
4 high-severity checks triggered. Individually each has an explanation; together they raise the chance that something structural is wrong rather than a one-off.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1Revenue growth stays above 138% a year✓ 184.2% CAGR
Latest reported year was 2.1%. The bar is set below the established compounding rate, so ordinary variation does not trip it.
2EBITDA margin holds above 5%✓ 7.4%
Two points below today's level — enough room for noise, tight enough to catch real compression.
3Free cash flow remains positive✗ -₹17 Cr
Profit that never becomes cash eventually stops being profit.
4Debt / EBITDA stays below 2x✓ 0.2x
The ratio lenders write covenants against; it survives a small or negative equity base, unlike Debt/Equity.
5ROCE stays above 28%✓ 30.5%
Falling returns on capital are usually competition arriving, and show up here before they reach the margin.

Investment Checklist

7 / 11 checks passed

✓ Strong return on equity (ROE ≥ 15%)
✓ Strong return on capital employed (ROCE ≥ 15%)
✗ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✗ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✓ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high
✗ Short-term technical trend isn't bearish

Price history

Quick Metrics

5 good · 4 neutral · 2 weak

Market Cap

₹17 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

1.9x

Cheap

Cheap against the generic band

P/B Ratio

0.51x

Reasonable

Reasonable against the company's book value

EPS (TTM)

₹18.25

Profitable

Profitable on a per-share basis

ROE

42.1%

Strong

Strong capital efficiency

ROCE

30.5%

Strong

Earns comfortably above its likely cost of capital

Debt/Equity

8.42x

High

High leverage

Revenue Growth (YoY)

2.1%

Modest

Modest growth

Profit Growth (YoY)

7.2%

Modest

Slow profit growth

Dividend Yield

None

No dividend yield reported — usually means no payout, but verify if one was recently initiated

Free Cash Flow

-₹20 Cr

Cash burning

Spending more cash than the operations bring in

More Metrics

CMP

₹34.98

ROA

13.0%

Good

Assets are working hard

Operating Margin

11.5%

Average

Average margins

Net Margin

5.8%

Average

Average bottom-line conversion

Current Ratio

2.65

Comfortable

Healthy short-term liquidity

Beta (vs Nifty)

1.11

Market-like

Moves roughly in line with the market

52W Range Position

Near low

Near its 52-week low

Technical Snapshot

SMA 20 / SMA 50

36.3 / 39.8

Bearish alignment (short < long)

Price vs SMA 200

Below

Long-term downtrend

RSI (14)

39.4

Neutral momentum

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹7 Cr	₹4 Cr	₹107 Cr	₹150 Cr	+184.2%
EBITDA	₹0 Cr	₹0 Cr	₹4 Cr	₹11 Cr	+328.1%
EBITDA Margin	2.2%	2.9%	3.4%	7.4%	—
PAT (Net Profit)	₹0 Cr	₹0 Cr	₹3 Cr	₹9 Cr	+1324.3%
EPS	₹0.01	₹0.01	₹13.27	—	—
ROE	0.1%	0.4%	31.9%	26.4%	—
ROCE	0.7%	0.4%	40.3%	30.5%	—
Total Debt	₹2 Cr	₹2 Cr	₹1 Cr	₹3 Cr	+6.3%
Free Cash Flow	-₹1 Cr	-₹3 Cr	-₹1 Cr	-₹17 Cr	—

🟢 Revenue has grown at 184.2% a year over 3 years.

🟢 EBITDA has grown at 328.1% a year over 3 years.

🟢 EBITDA Margin has risen from 2.2% to 7.4% over 3 years (+5.3 pts).

🟢 PAT (Net Profit) has grown at 1324.3% a year over 3 years.

🟢 ROE has risen from 0.1% to 26.4% over 3 years (+26.3 pts).

🟢 ROCE has risen from 0.7% to 30.5% over 3 years (+29.9 pts).

🔴 Total Debt has grown at 6.3% a year over 3 years.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹49 Cr

Total Liabilities

₹16 Cr

Total Debt

₹3 Cr

Cash & Equivalents

₹0 Cr

Operating Cash Flow

-₹10 Cr

Capex

-₹8 Cr

Shareholding (proxy)

Institutional Holding

0.0%

Insider Holding

61.0%

Peer Comparison

Company	P/E	ROE
NESTLE INDIA LIMITED	59.8x	79.9%
BRITANNIA INDUSTRIES LTD	44.1x	51.0%
TATA CONSUMER PRODUCT LTD	59.3x	7.5%
DABUR INDIA LTD	34.7x	17.2%

Recent News

6 general

Sonalis Consumer Products postpones board meeting to May 27

scanx.trade, 26 May

Sonalis Consumer Products Ltd Key Financial Ratios – Valuation, Profitability & More

Value Research, 31 Aug

EMMBI INDUSTRIES Stock/Share price , NSE/BSE Forecast News and Live Quotes

Equitymaster, 15 Oct

Sonalis Consumer Products sets Sep 28 AGM date

scanx.trade, 03 Sept

Pradhin (BSE:530095) - Stock Analysis

Simply Wall Street, 07 Jun

Sonalis Consumer Products Rights Issue 2025 Date, Price, Allotment, Ratio

IPO Watch, 28 Mar

Watch Items

Trading very close to its 52-week low — worth checking whether this reflects a temporary setback or a structural problem.
Cross-check against the company's latest quarterly filing / investor presentation before acting.

DalalBaazaar Thesis

🟡Business QualityAdequate12.4/20

🟡Financial HealthAdequate10.6/20

🟢GrowthStrong14.9/20

🟢ProfitabilityStrong11.8/15

🟢ValuationAttractive13.2/15

🔴RiskHigh3.3/10

Attractive on both counts

A good business currently available at an undemanding price — the combination this framework exists to look for. The work left is qualitative: whether the advantage the numbers imply is one you can identify and expect to last. 4 high-severity red flags sit above this conclusion and should be read first.

This thesis breaks if

✓Revenue growth stays above 138% a year184.2% CAGR
✓EBITDA margin holds above 5%7.4%
✗Free cash flow remains positive-₹17 Cr
✓Debt / EBITDA stays below 2x0.2x
✓ROCE stays above 28%30.5%